Generali Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$339 Hold
25
﹤0.01% 526
2026
Q1
$150 Hold
25
﹤0.01% 484
2025
Q4
$179 Hold
25
﹤0.01% 483
2025
Q3
$267 Hold
25
﹤0.01% 499
2025
Q2
$242 Hold
25
﹤0.01% 498
2025
Q1
$372 Hold
25
﹤0.01% 494
2024
Q4
$373 Buy
+25
New +$407 ﹤0.01% 479

Other funds holding OGN

Generali Asset Management's OGN Position: Q2 2026 in Review

Generali Asset Management held its Organon & Co (OGN) position steady in Q2 2026 at 25 shares worth $339. The position accounts for ﹤0.01% of the portfolio, ranked #526.

Generali Asset Management first reported a position in OGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $373 in Q4 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Generali Asset Management held 25 shares of Organon & Co worth $339 as of Q2 2026.
  • Generali Asset Management left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Generali Asset Management's portfolio in Q2 2026, its #526 holding.
  • Generali Asset Management first reported a position in Organon & Co in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's Organon & Co position peaked at $373 in Q4 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.